Investment Stage

Focus Areas

About Investor

Cristina Ghenoiu is a life sciences investor currently serving as a Senior Principal in Mubadala Capital’s healthcare venture business; the profile you provided reflects her prior role as Principal at RA Capital Management. In that prior RA Capital role her investing was focused on biotech and pharmaceutical companies across seed through later private rounds, with a documented investment range of $100K to $5.0M and a sweet spot around $1.5M. Her background includes vice president roles on the biotech team at Longitude Capital, where she helped spin out and build companies such as Rivus and 89bio, and a senior operating role at Epirium Bio as SVP of R&D Operations and New Product Planning. She holds a PhD in biology from Rockefeller University and completed postdoctoral research in chromatin biology at Harvard Medical School.